Cargando…

Selective Wnt/β-Catenin Pathway Activation Concomitant With Sustained Overexpression of miR-21 is Responsible for Aristolochic Acid-Induced AKI-to-CKD Transition

Acute kidney injury (AKI) is increasingly recognized as a cumulative risk factor for chronic kidney disease (CKD) progression. However, the underlying mechanisms remain unclear. Using an aristolochic acid (AA)-induced mouse model of AKI-to-CKD transition, we found that the development of tubulointer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuang, Qing, Wu, Sheng, Xue, Ning, Wang, Xiaoyan, Ding, Xiaoqianq, Fang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193720/ https://www.ncbi.nlm.nih.gov/pubmed/34122087 http://dx.doi.org/10.3389/fphar.2021.667282

Ejemplares similares

Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition
por: Baudoux, Thomas, et al.
Publicado: (2022)

Infectious consequences of the AKI-to-CKD transition
por: Sánchez Horrillo, Ana, et al.
Publicado: (2022)

Activation of EP4 alleviates AKI-to-CKD transition through inducing CPT2-mediated lipophagy in renal macrophages
por: Guan, Xu, et al.
Publicado: (2022)

The AKI-to-CKD Transition: The Role of Uremic Toxins
por: André, Camille, et al.
Publicado: (2023)

Oroxylin A ameliorates AKI-to-CKD transition through maintaining PPARα-BNIP3 signaling-mediated mitochondrial homeostasis
por: Yao, Mengying, et al.
Publicado: (2022)

Meta-analysis of AKI to CKD transition in perioperative patients
por: M. Abdala, Pedro, et al.
Publicado: (2021)

Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition
por: Tanemoto, Fumiaki, et al.
Publicado: (2022)

EGFR drives the progression of AKI to CKD through HIPK2 overexpression
por: Xu, Luyang, et al.
Publicado: (2019)

Systematic Overview of Aristolochic Acids: Nephrotoxicity, Carcinogenicity, and Underlying Mechanisms
por: Han, Jiayin, et al.
Publicado: (2019)

Dynamic signature of lymphangiogenesis during AKI and CKD
por: Zarjou, Abolfazl, et al.
Publicado: (2019)

The potential roles of galectin-3 in AKI and CKD
por: Wang, Fengyun, et al.
Publicado: (2023)

AKI-to-CKD transition is a potential mechanism for non-albuminuric diabetic kidney disease
por: Lee, Kyung, et al.
Publicado: (2022)

Depletion of macrophages with clodronate liposomes partially attenuates renal fibrosis on AKI–CKD transition
por: Hu, Zhizhi, et al.
Publicado: (2023)

Altered gut microbiome plays an important role in AKI to CKD transition in aged mice
por: Kim, Myung-Gyu, et al.
Publicado: (2023)

From AKI to CKD: Maladaptive Repair and the Underlying Mechanisms
por: Wang, Zhiwen, et al.
Publicado: (2022)

REST contributes to AKI-to-CKD transition through inducing ferroptosis in renal tubular epithelial cells
por: Gong, Shuiqin, et al.
Publicado: (2023)

Role of miRNA-671-5p in Mediating Wnt/β-Catenin-Triggered Podocyte Injury
por: Wang, Chunhong, et al.
Publicado: (2022)

Hydrogen-Rich Saline Alleviates Kidney Fibrosis Following AKI and Retains Klotho Expression
por: Chen, Jing, et al.
Publicado: (2017)

The VEGF Inhibitor Soluble Fms-like Tyrosine Kinase 1 Does Not Promote AKI-to-CKD Transition
por: van Aanhold, Cleo C. L., et al.
Publicado: (2022)

Roles of interferon regulatory factor 4 in the AKI-CKD transition, glomerular diseases and kidney allograft rejection
por: Song, Jianling, et al.
Publicado: (2023)

The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation
por: Kant, Sam, et al.
Publicado: (2020)

IL-18 deficiency ameliorates the progression from AKI to CKD
por: Luan, Junjun, et al.
Publicado: (2022)

Regulatory Mechanisms of the Wnt/β-Catenin Pathway in Diabetic Cutaneous Ulcers
por: Zhang, Han, et al.
Publicado: (2018)

AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2018)

USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway
por: Xue, Sudong, et al.
Publicado: (2020)

Sepsis-induced AKI: From pathogenesis to therapeutic approaches
por: He, Fang-Fang, et al.
Publicado: (2022)

Glycyrrhizic Acid Promotes Osteogenic Differentiation of Human Bone Marrow Stromal Cells by Activating the Wnt/β-Catenin Signaling Pathway
por: Bai, Jinwu, et al.
Publicado: (2021)

Aberrant Wnt/Beta-Catenin Pathway Activation in Dialysate-Induced Peritoneal Fibrosis
por: Guo, Yuanyuan, et al.
Publicado: (2017)

Interplay Between Ion Channels and the Wnt/β-Catenin Signaling Pathway in Cancers
por: Rapetti-Mauss, Raphael, et al.
Publicado: (2020)

Curcumin Suppresses the Colon Cancer Proliferation by Inhibiting Wnt/β-Catenin Pathways via miR-130a
por: Dou, Huiqiang, et al.
Publicado: (2017)

Recombinant Long-Acting Thioredoxin Ameliorates AKI to CKD Transition via Modulating Renal Oxidative Stress and Inflammation
por: Nishida, Kento, et al.
Publicado: (2021)

Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2020)

Corrigendum: USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway
por: Xue, Sudong, et al.
Publicado: (2020)

RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD
por: Chen, Hui, et al.
Publicado: (2018)

The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
por: Guo, Runzhi, et al.
Publicado: (2023)

Pharmacological mechanisms of Fuzheng Huayu formula for Aristolochic acid I–induced kidney fibrosis through network pharmacology
por: Wang, Fan, et al.
Publicado: (2022)

PKC-ζ Aggravates Doxorubicin-Induced Cardiotoxicity by Inhibiting Wnt/β-Catenin Signaling
por: Cao, Yan-Jun, et al.
Publicado: (2022)

Editorial: Non-coding RNA and Wnt/β-Catenin Signaling Pathway in Human Cancer
por: Waye, Mary Miu Yee, et al.
Publicado: (2022)

Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathway
por: Zhao, Jing, et al.
Publicado: (2023)

Ferroptosis and Acute Kidney Injury (AKI): Molecular Mechanisms and Therapeutic Potentials
por: Feng, Qi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_21ate8sd7reaajbe77nrbgjl60